BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 16195396)

  • 1. Quality control of fibrinogen secretion in the molecular pathogenesis of congenital afibrinogenemia.
    Vu D; Di Sanza C; Caille D; de Moerloose P; Scheib H; Meda P; Neerman-Arbez M
    Hum Mol Genet; 2005 Nov; 14(21):3271-80. PubMed ID: 16195396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manipulating the quality control pathway in transfected cells: low temperature allows rescue of secretion-defective fibrinogen mutants.
    Vu D; Di Sanza C; Neerman-Arbez M
    Haematologica; 2008 Feb; 93(2):224-31. PubMed ID: 18223281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in the fibrinogen gene cluster accounting for congenital afibrinogenemia: an update and report of 10 novel mutations.
    Neerman-Arbez M; de Moerloose P
    Hum Mutat; 2007 Jun; 28(6):540-53. PubMed ID: 17295221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congenital hypofibrinogenemia: characterization of two missense mutations affecting fibrinogen assembly and secretion.
    Platè M; Asselta R; Spena S; Spreafico M; Fagoonee S; Peyvandi F; Tenchini ML; Duga S
    Blood Cells Mol Dis; 2008; 41(3):292-7. PubMed ID: 18676163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypofibrinogenaemia caused by a novel FGG missense mutation (W253C) in the gamma chain globular domain impairing fibrinogen secretion.
    Vu D; de Moerloose P; Batorova A; Lazur J; Palumbo L; Neerman-Arbez M
    J Med Genet; 2005 Sep; 42(9):e57. PubMed ID: 16141000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Iranian patients allowed the identification of the first truncating mutation in the fibrinogen Bbeta-chain gene causing afibrinogenemia.
    Asselta R; Spena S; Duga S; Peyvandi F; Malcovati M; Mannucci PM; Tenchini ML
    Haematologica; 2002 Aug; 87(8):855-9. PubMed ID: 12161363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational screening of six afibrinogenemic patients: identification and characterization of four novel molecular defects.
    Monaldini L; Asselta R; Duga S; Peyvandi F; Karimi M; Malcovati M; Tenchini ML
    Thromb Haemost; 2007 Apr; 97(4):546-51. PubMed ID: 17393016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and functional characterization of a novel nonsense mutation in FGA accounting for congenital afibrinogenemia in six Egyptian patients.
    Abdel Wahab M; de Moerloose P; Fish RJ; Neerman-Arbez M
    Blood Coagul Fibrinolysis; 2010 Mar; 21(2):164-7. PubMed ID: 20051841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of 7 patients affected by dys- or hypo-dysfibrinogenemia: Identification of a novel mutation in the fibrinogen Bbeta chain causing a gain of glycosylation.
    Asselta R; Robusto M; Platé M; Santoro C; Peyvandi F; Duga S
    Thromb Res; 2015 Jul; 136(1):168-74. PubMed ID: 26006300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel fibrinogen Bbeta chain frameshift mutation in a patient with severe congenital hypofibrinogenaemia.
    Xu X; Wu J; Zhai Z; Zhou R; Wang X; Wang H; Ding K; Sun Z; Ni H
    Thromb Haemost; 2006 Jun; 95(6):931-5. PubMed ID: 16732370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fibrinogen beta chain gene mutation contributes to one congenital afibrinogenemia].
    Xu XC; Zhou RF; Wu JS; Fang Y; Wang XF; Zhai ZM; Wang HL
    Zhonghua Xue Ye Xue Za Zhi; 2005 Mar; 26(3):137-9. PubMed ID: 15946523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel fibrinogen B beta chain frameshift mutation causes congenital afibrinogenaemia.
    Zhang J; Zhao X; Wang Z; Yu Z; Cao L; Zhang W; Bai X; Ruan C
    Thromb Haemost; 2013 Jul; 110(1):76-82. PubMed ID: 23740095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital afibrinogenemia: identification and expression of a missense mutation in FGB impairing fibrinogen secretion.
    Vu D; Bolton-Maggs PH; Parr JR; Morris MA; de Moerloose P; Neerman-Arbez M
    Blood; 2003 Dec; 102(13):4413-5. PubMed ID: 12893758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A deep intronic mutation in FGB creates a consensus exonic splicing enhancer motif that results in afibrinogenemia caused by aberrant mRNA splicing, which can be corrected in vitro with antisense oligonucleotide treatment.
    Davis RL; Homer VM; George PM; Brennan SO
    Hum Mutat; 2009 Feb; 30(2):221-7. PubMed ID: 18853456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel frameshift mutation in FGA accounting for congenital afibrinogenemia predicted to encode an aberrant peptide terminating 158 amino acids downstream.
    Robert-Ebadi H; de Moerloose P; El Khorassani M; El Khattab M; Neerman-Arbez M
    Blood Coagul Fibrinolysis; 2009 Jul; 20(5):385-7. PubMed ID: 19417632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital afibrinogenemia: Identification and characterization of two novel homozygous fibrinogen Aα and Bβ chain mutations in two Tunisian families.
    Amri Y; Toumi Nel H; Hadj Fredj S; de Moerloose P
    Thromb Res; 2016 Jul; 143():11-6. PubMed ID: 27164460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FGB mutations leading to congenital quantitative fibrinogen deficiencies: an update and report of four novel mutations.
    Casini A; Lukowski S; Quintard VL; Crutu A; Zak M; Regazzoni S; de Moerloose P; Neerman-Arbez M
    Thromb Res; 2014 May; 133(5):868-74. PubMed ID: 24560896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Missense mutations in the human beta fibrinogen gene cause congenital afibrinogenemia by impairing fibrinogen secretion.
    Duga S; Asselta R; Santagostino E; Zeinali S; Simonic T; Malcovati M; Mannucci PM; Tenchini ML
    Blood; 2000 Feb; 95(4):1336-41. PubMed ID: 10666208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Congenital afibrinogenemia caused by a novel insertion mutation in the FGB gene].
    Zhang J; Zhao XJ; Wang ZY; Yu ZQ; Cao LJ; Ma ZN; Zhang J; Zhang W; Bai X; Ruan CG
    Zhonghua Xue Ye Xue Za Zhi; 2013 Sep; 34(9):751-6. PubMed ID: 24103871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of the first missense mutation in the fibrinogen Aalpha-chain gene identified in a compound heterozygous afibrinogenemic patient.
    Platé M; Asselta R; Peyvandi F; Tenchini ML; Duga S
    Biochim Biophys Acta; 2007 Jul; 1772(7):781-7. PubMed ID: 17531448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.